Streptococcal Vaccine
Rhesus macaque model to assess Streptococcus pneumoniae vaccines developed
Published in Vaccine Weekly, July 5th, 2006
"We explored the possibility of using normal adult rhesus macaques for the preclinical assessment of safety, immunogenicity, and efficacy of newly developed vaccines against Streptococcus pneumoniae infection of the lung. Our primary objective was to determine whether an intra-bronchial inoculum of at least 106S. pneumoniae colony-forming units, or one as high as 108-109 organisms, could detectably survive in rhesus macaques for a period longer than one to two weeks," researchers in the United States report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-07-05)
More Articles from Vaccine Weekly
- Allergy Medicine
DNA vaccines and allergic diseases reviewed - Alzheimer Disease Vaccine
Anti-A-beta single-chain antibody reduces amyloid load in Alzheimer mouse model - Escherichia Coli Vaccine
Plant-based vaccine protects against intoxication by Shiga toxin - SARS Vaccine
Amino acid substitution in SARS coronavirus spike protein disrupts binding - Adaptive Immune Response
IFN-alpha/beta-dependent cross-priming induced by specific toll-like receptor agonists - Allergy & Immunology
Dynavax announces completion of enrollment in Tolamba ragweed allergy trial - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
